Keyphrases
Anatomic
100%
Treatment-resistant
100%
Anti-vascular Endothelial Growth Factor Therapy
100%
Dexamethasone Intravitreal Implant
100%
Polypoidal Choroidal Vasculopathy
100%
Dexamethasone Implant
100%
Anti-vascular Endothelial Growth Factor Injection
44%
Visual Acuity
22%
Optical Coherence Tomography
22%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
22%
Free Interval
22%
Best-corrected Visual Acuity
22%
Monotherapy
11%
Kaplan-Meier
11%
After Injection
11%
Primary Outcome Measure
11%
Follow-up Interval
11%
First Injection
11%
Pre-injection
11%
Fundus
11%
Slit Lamp Examination
11%
Retinal Thickness
11%
Anatomical Response
11%
Treatment-free Interval
11%
Medicine and Dentistry
Implant
100%
Vasculotropin
100%
Dexamethasone
100%
Polypoidal Choroidal Vasculopathy
100%
Intravitreal Implant
81%
Visual Acuity
18%
Optical Coherence Tomography
18%
Best Corrected Visual Acuity
18%
Monotherapy
9%
Retrospective Study
9%
Slit Lamp Microscopy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Dexamethasone
100%
Vasculotropin
100%
Implant
100%
Polypoidal Choroidal Vasculopathy
100%
Monotherapy
9%
Retrospective Study
9%
Neuroscience
Vascular Disease
100%
Vascular Endothelial Growth Factor
100%
Dexamethasone
100%
Optics
18%